🔎 Trials Near Me

Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Kansas

Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Kansas

5 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in Kansas.

Cities in Kansas

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Site Number - 1602, Kansas City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07032662

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • University of Kansas Medical Center, Kansas City
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05327114

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • University of Kansas Medical Center- Site Number : 8400010, Kansas City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06290141

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

  • Clinical Study Site, Kansas City
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT06858579

A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care

  • University of Kansas Medical Center Research Institute, Inc., Kansas City
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT06538064

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.